Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F18DX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $133,326
Award facts
- Contract value 100% obligated
- $133,325.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $133,325.68 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of November 18, 2025. The contract is issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order supports the DLA Medical Supply Chain's mission to provision pharmaceutical products for military and veteran healthcare systems. Dupixent (dupilumab) is a biologic immunosuppressant used to treat moderate-to-severe eczema, asthma, and other allergic conditions. AmerisourceBergen, as a major pharmaceutical distributor serving federal medical procurement needs, leverages its IDC vehicle to fulfill critical healthcare commodity requirements across the Department of Defense. The award reflects the company's established capability to deliver brand-name specialty medications competitively to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F18DX?
SPE2DR26F18DX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F18DX worth?
The government has obligated $133,326 on SPE2DR26F18DX.
Is contract SPE2DR26F18DX an order under another contract?
Yes. SPE2DR26F18DX is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18DX competed?
The extent of competition for SPE2DR26F18DX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award